2Medical.News
366 subscribers
683 photos
47 files
4.84K links
Every Day, 2Medical.News from the most Trusted Journals
https://2medical.news
Aldo Lorenzetti M.D, Internal Medicine & Hepatology, Milano - SIMEDET Delegate
Download Telegram
!!
#Preterm birth and risk of chronic #kidney disease from childhood into mid-adulthood: national cohort study

https://www.bmj.com/content/365/bmj.l1346

Preterm birth and extremely preterm birth (<28 weeks) were associated with nearly twofold and threefold risks of CKD, respectively, from birth into mid-adulthood (adjusted hazard ratio 1.94, 95% confidence interval 1.74 to 2.16; P<0.001; 3.01, 1.67 to 5.45; P<0.001). An increased risk was observed even among those born at early term (37-38 weeks) (1.30, 1.20 to 1.40; P<0.001). The association between preterm birth and CKD was strongest at ages 0-9 years (5.09, 4.11 to 6.31; P<0.001), then weakened but remained increased at ages 10-19 years (1.97, 1.57 to 2.49; P<0.001) and 20-43 years (1.34, 1.15 to 1.57; P<0.001). These associations affected both males and females and did not seem to be related to shared genetic or environmental factors in families.

Conclusions Preterm and early term birth are strong risk factors for the development of CKD from childhood into mid-adulthood. People born prematurely need long term follow-up for monitoring and preventive actions to preserve renal function across the life course.
Saving Veins, Saving Lives, for Patients With Chronic #Kidney Disease

https://annals.org/aim/article-abstract/2735183/saving-veins-saving-lives-patients-chronic-kidney-disease

Vascular access has long been recognized as the Achilles' heel of the management of patients receiving maintenance hemodialysis. Such patients require cannulation with 15-gauge needles 3 times weekly, blood flows of about 400 mL/min, and treatments of 4 to 5 hours per session. This requires creation of arteriovenous fistulae using native veins or arteriovenous grafts using synthetic vein material. Absent usable vessels or time to surgically create and allow maturation of internal access for dialysis, clinicians use large-bore, dual-lumen, tunneled, cuffed dialysis catheters placed in the internal jugular vein. Robust data show that mortality among patients receiving dialysis with #catheters is about 1.6 to 2.5 times higher than among those with internal access and no catheter. The higher rate of catheter use in U.S. hemodialysis patients likely explains the observed higher mortality compared with that in other countries (1, 2)..
!!
Benefits and Harms of Oral #Anticoagulant Therapy in Chronic #Kidney Disease: A Systematic Review and Meta-analysis

https://annals.org/aim/article-abstract/2738158/benefits-harms-oral-anticoagulant-therapy-chronic-kidney-disease-systematic-review

All but the 8 trials involving patients with ESKD excluded participants with creatinine clearance less than 20 mL/min or estimated glomerular filtration rate less than 15 mL/min/1.73 m2. In AF, compared with VKAs, NOACs reduced risks for stroke or systemic embolism (risk ratio RR, 0.79 95% CI, 0.66 to 0.93; high-certainty evidence) and hemorrhagic stroke (RR, 0.48 CI, 0.30 to 0.76; moderate-certainty evidence). Compared with VKAs, the effects of NOACs on recurrent VTE or VTE-related death were uncertain (RR, 0.72 CI, 0.44 to 1.17; low-certainty evidence). In all trials combined, NOACs seemingly reduced major bleeding risk compared with VKAs (RR, 0.75 CI, 0.56 to 1.01; low-certainty evidence).

Conclusion:
In early-stage CKD, NOACs had a benefit–risk profile superior to that of VKAs. For advanced CKD or ESKD, there was insufficient evidence to establish benefits or harms of VKAs or NOACs.
!!
Acute #Kidney Injury Among Older Patients Undergoing Coronary #Angiography for Acute Myocardial Infarction: The SILVER-AMI Study

..Comorbid diseases and aging-related conditions were both more common among individuals experiencing acute kidney injury. However, after multivariable adjustment, no aging-related conditions were retained. There were 11 risk factors in the final model; the strongest were heart failure on presentation (odds ratio [OR] 1.91; 95% confidence interval [CI], 1.41-2.59), body mass index [BMI] >30 (vs BMI 18-25: OR 1.75; 95% CI, 1.27-2.42), and nonwhite race (OR 1.65; 95% CI, 1.16-2.33). The final model achieved an area under the receiver operating characteristic curve of 0.72 and was well calibrated (Hosmer-Lemeshow P = .50). Acute kidney injury was independently associated with 6-month mortality (OR 1.98; 95% CI, 1.36-2.88) but not readmission (OR 1.26; 95% CI, 0.98-1.61).

Conclusions
Acute kidney injury is common among older adults with acute myocardial infarction undergoing coronary angiography. Predictors largely mirrored those in previous studies of younger individuals, which suggests that geriatric conditions mediate their influence through other risk factors

https://bit.ly/38zXjxL
Acute #kidney injury after primary total hip #arthroplasty: a risk multiplier for complication, mortality, and healthcare utilization
https://2medical.news/2020/03/17/acute-kidney-injury-after-primary-total-hip-arthroplasty-a-risk-multiplier-for-complication-mortality-and-healthcare-utilization/

To assess whether acute kidney injury (AKI) is associated with more complications and higher healthcare utilization in people undergoing primary total hip arthroplasty (THA).. ..Adjusted for age, gender, race, income, underlying diagnosis, medical comorbidity, and the insurance payer, AKI in people who underwent primary THA was associated with significantly higher OR (95% CI) of (1) implant infection, 2.34 (95% CI, 1.87, 2.93); (2) transfusion, 2.46 …
EMA advises continued use of medicines for #hypertension, heart or #kidney disease during COVID-19 pandemic
https://2medical.news/2020/04/02/ema-advises-continued-use-of-medicines-for-hypertension-heart-or-kidney-disease-during-covid-19-pandemic/

EMA is aware of recent media reports and publications which question whether some medicines, for instance angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs, or sartan medicines), could worsen coronavirus disease (COVID-19). ACE inhibitors and ARBs are most commonly used for treating patients with high blood pressure, heart failure or kidney disease. It is important that patients do not interrupt their treatment with …
ACUTE #KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH #COVID-19
https://2medical.news/2020/05/21/acute-kidney-injury-in-patients-hospitalized-with-covid-19/

The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients …
The change in #kidney function was associated with #carotid artery plaque in a community-based population: a cohort study
https://2medical.news/2020/09/01/the-change-in-kidney-function-was-associated-with-carotid-artery-plaque-in-a-community-based-population-a-cohort-study/

We performed the current study to evaluate the association between dynamic change in estimated glomerular filtration rate (eGFR) and the risk of carotid artery plaque (CAP) in a community-based population A total number of 37,093 Chinese adults (21,790 men and 15,303 women, aged 42.6±11.6 years) free of chronic kidney diseases were enrolled. The change in eGFR was calculated based on two measurements in 2013 and …
Natural history of acute #kidney disease in patients with #cirrhosis
https://2medical.news/2020/09/17/natural-history-of-acute-kidney-disease-in-patients-with-cirrhosis/

In 2012, KDIGO group proposed new definitions for Acute Kidney Injury (AKI), Acute Kidney Disease (AKD) and Chronic Kidney Disease (CKD). According to the definition adapted by the International Club of Ascites (ICA), AKI has been extensively investigated in patients with cirrhosis. On the contrary, there are currently no data on the epidemiology and clinical outcome of AKD in these patients. The aim of the …
#Dapagliflozin in Patients with Chronic #Kidney Disease
https://2medical.news/2020/09/28/dapagliflozin-in-patients-with-chronic-kidney-disease/

Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diabetes, is not known.. ..The independent data monitoring committee recommended stopping the trial because of efficacy. Over a median of 2.4 years, a primary outcome event occurred in 197 of 2152 participants (9.2%) in the …
#Hypoalbuminemia is associated with increased risk of acute #kidney injury in hospitalized patients: A meta-analysis
https://2medical.news/2020/10/24/hypoalbuminemia-is-associated-with-increased-risk-of-acute-kidney-injury-in-hospitalized-patients-a-meta-analysis/

Highlights • Each 1.0 g/dL of serum albumin decrement was associated with increased odds of AKI (OR 1.685; 95% CI, 1.302–2.179). • The risk factors for AKI in hypoalbuminemic patients include 1) age ≥ 70 years and 2) baseline serum albumin level > 3.2 g/dL. • The association between hypoalbuminemia and overall mortality from AKI remained inconclusive as there was potential publication bias. https://bit.ly/2HeU31v
Low High‐Sensitivity C‐ #Reactive Protein Level in Korean Patients With Chronic #Kidney Disease and Its Predictive Significance for Cardiovascular Events, Mortality, and Adverse Kidney Outcomes: Results From KNOW‐CKD
https://2medical.news/2020/11/01/low-high%E2%80%90sensitivity-c%E2%80%90-reactive-protein-level-in-korean-patients-with-chronic-kidney-disease-and-its-predictive-significance-for-cardiovascular-events-mortality-and-adverse-kidney/

Inflammation levels are lower in East Asians than in Western people. We studied the association between high‐sensitivity hs‐CRP (C‐reactive protein) and adverse outcomes in Korean patients with chronic kidney disease. Methods and Results We included 2018 participants from the KNOW‐CKD (Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease) between April 2011 and February 2016. The primary outcome was a composite of extended …
The #Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for #Diabetes Management in Chronic Kidney Disease (CKD)
https://2medical.news/2020/11/14/the-kidney-disease-improving-global-outcomes-kdigo-2020-clinical-practice-guideline-for-diabetes-management-in-chronic-kidney-disease-ckd/

Here attached you may find the takeaways of the guidelines for patients and for clinicians. takeaways for patients: https://kdigo.org/wp-content/uploads/2018/03/Top-10-Takeaways-Patients.pdf takeaways for clinicians: https://kdigo.org/wp-content/uploads/2018/03/Top-10-Takeaways-Clinicians.pdf